InsidersTradesSigma
Explore the complete record of transactions filed by Gayer Charles K, Directeur Commercial. Director active across 1 company, notably Biocryst Pharmaceuticals INC. In total, 4 disclosures have been recorded. History available since 14 December 2021. The latest transaction was disclosed on 14 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations
Charles K. Gayer is Chief Commercial Officer at Biocryst Pharmaceuticals Inc. He is responsible for the company's commercial strategy and business development. His expertise in the pharmaceutical sector is essential to support Biocryst's growth.